Cargando…
Transcatheter aortic valve replacement (TAVR): expanding indications to low-risk patients
Aortic stenosis (AS) is the most common cardiac valve disease in developed countries. Transcatheter aortic valve replacement (TAVR) for the treatment of severe symptomatic AS is an accepted therapy option for elderly patients with symptomatic severe AS. Nowadays, TAVR has revolutionized the treatmen...
Autores principales: | Cubero-Gallego, Hector, Dam, Christian, Meca, Juan, Avanzas, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475389/ https://www.ncbi.nlm.nih.gov/pubmed/32953760 http://dx.doi.org/10.21037/atm.2020.03.155 |
Ejemplares similares
-
Long term follow up of percutaneous treatment for degenerated Mitroflow prosthesis with self-expanding transcatheter aortic valve implantation
por: Pascual, Isaac, et al.
Publicado: (2020) -
Functional mitral regurgitation: structural modifications with percutaneous valve repair with MitraClip
por: Alperi, Alberto, et al.
Publicado: (2020) -
Initial experience of a MitraClip valve repair program in Spain
por: Henández-Vaquero, Daniel, et al.
Publicado: (2020) -
Outcomes with percutaneous mitral repair vs. optimal medical treatment for functional mitral regurgitation: systematic review
por: Cubero-Gallego, Hector, et al.
Publicado: (2020) -
A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)